Now more than ever, Pharmacoeconomics has become an important subject within the Healthcare Industry. Various payers are requiring pharmacoeconomic studies to determine whether they will be listing new products on formularies. Whether you are a Sales Representative; a specialist in Access; or you are working in Regulatory Affairs or Public Affairs, Pharmacoeconomics is playing an ever increasing importance to you and your customers. Basic Pharmacoeconomics is a stand-alone course that covers a wide range of topics which act to provide a solid foundation of pharmacoeconomic principles to the student. The course is a mandatory pre-requisite for CCPE’s Advanced Pharmacoeconomics course. Students who have completed CCPE’s Pharmacoeconomics course up to November 2016 are eligible to take Basic Pharmacoeconomics for full credit as a way to re-train in this area.
After completing the course, students will be able to:
- Discuss the foundations of Pharmacoeconomics
- Calculate and discuss QALYs and ICERs given the appropriate data
- Describe how to compare treatment options
- 60 multiple choice questions
- Suggested Hours of Study 30
- Quizzes 0
- Suggested Hours of Study 14 hrs
- Course Completion 3 months
- Course Format Paper w/ PDF
- RxTx No
- Language English
- Pages 143 pages
- C.E. Credits What is this? 1.5
- Orientation Package
- # of Questions 60
- Time Limit 90 min.
- Passing Grade 60%
- Price $1,060.00
- Corporate Member $530.00
- Corporate Non-Member $2,650.00
CHAPTER 1: Introduction to Pharmacoeconomics and the Course
- Describe what pharmacoeconomics is and how it differs from health economics
- State the main objectives of beginner and advanced pharmacoeconomic modules
- State the main purpose of using pharmacoeconomics in health care
- Describe what is meant by “value for money”
- Describe what a health technology assessment is
CHAPTER 2: Fundamentals of Pharmacoeconomics
CHAPTER 3: Defining, Measuring and Estimating Health Care Costs
- Describe the common health care costs considered in pharmacoeconomic evaluations
- Define, contrast and compare the following pharmacoeconomic terms: opportunity cost, marginal cost, direct medical costs, direct nonmedical costs, indirect costs and intangible costs.
- Define the term “discounting” and discuss how it applies in pharmacoeconomic evaluations.
- Describe two ways of measuring and estimating health care costs.
CHAPTER 4: Defining, Measuring and Estimating Health Care Outcomes
- Describe three health care outcomes considered in pharmacoeconomic evaluations.
- Define, contrast and compare the following pharmacoeconomic terms: utility, quality of adjusted life-year, efficacy and effectiveness.
- Describe three methods (e.g., rating scale, standard gamble, and time trade-off) for estimating utility of health care outcomes.
CHAPTER 5: Types of Pharmacoeconomic Analysis.
- Describe situations in which a cost analysis, a cost-minimization analysis, a cost-effectiveness analysis, a cost-utility analysis, or a cost-benefit analysis should be used.
- Compare and contrast the advantages and disadvantages of a costminimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis.
- Describe the significance and calculation of an Incremental CostEffectiveness Ratio (ICER).
- Interpret a cost-effectiveness plane.
- Describe the significance and calculation of a Quality-Adjusted Life Year (QALY) and its relationship to a cost-utility analysis.
- Be able to compare net benefits, benefit-to-cost ratios, and internal rate of return as methods of representing cost-benefit analyses.
CHAPTER 6: Deriving pharmacoeconomic data from clinical trials
CHAPTER 7: Practical Application of Pharmacoeconomics
- Describe how clinicians and drug policy decision makers use pharmacoeconomic data to make recommendations for using a treatment.
- Explain why it is important to be aware of pharmacoeconomic data of a treatment when discussing a treatment option with other health care professionals
- Discuss the application of pharmacoeconomic data for marketing a product
- Describe how pharmacoeconomic data is applied when making decisions for listing a drug on a Provincial or Hospital Formulary
- List what questions to consider when reviewing pharmacoeconomic data and applying it to a health care related decision